부산대학교 도서관

Urticarial, purpuric, maculopapular and acral rashes have been described in the literature to date.1,2 We report a patient presenting with toxic erythema as the first sign of COVID-19 infection. We consider it important to recognize COVID-19 infection as a differential for a toxic exanthemous skin eruption during this pandemic, especially in the context of novel treatments that may improve mortality. During the COVID-19 pandemic, dermatologists have sought to identify and categorize skin manifestations associated with COVID-19, in the hope that it will aid early recognition and treatment of the condition, and provide insight into the pathophysiology of the disease. [Extracted from the article]